Avanos Medical (AVNS) Enterprise Value (2013 - 2026)

Avanos Medical has disclosed Enterprise Value across 14 years of filings, most recently posting -$65.6 million for Q1 2026.

• Enterprise Value for Q1 2026 came in at -$65.6 million, up 32.37% year-over-year; the trailing twelve-month figure through Mar 2026 was -$65.6 million (up 32.37% YoY), and the FY2025 annual result was -$89.8 million, up 16.62% from the prior year.
• Enterprise Value came in at -$65.6 million for Q1 2026 at Avanos Medical, up from -$89.8 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$65.6 million in Q1 2026 to a low of -$127.7 million in Q4 2022.
• The 5-year median for Enterprise Value is -$92.2 million (2024), against an average of -$94.5 million.
• Across the five-year window, Enterprise Value declined 27.97% in 2025 and surged 32.37% in 2026, its largest moves.
• Avanos Medical's Enterprise Value stood at -$127.7 million in 2022, then surged by 31.32% to -$87.7 million in 2023, then dropped by 22.81% to -$107.7 million in 2024, then increased by 16.62% to -$89.8 million in 2025, then increased by 26.95% to -$65.6 million in 2026.
• The last three Enterprise Value figures came in at -$65.6 million (Q1 2026), -$89.8 million (Q4 2025), and -$70.5 million (Q3 2025), per Business Quant data.